Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial
| Title: | Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial |
|---|---|
| Authors: | Jonathan Weyne, Andrew Blauvelt, Marjolein de Bruin-Weller, Errol Prens, Penny Asbell, Debra Sierka, Zhen Chen, Brad Shumel |
| Source: | Dermatology and Therapy, Vol 10, Iss 6, Pp 1415-1421 (2020) |
| Publisher Information: | Adis, Springer Healthcare, 2020. |
| Publication Year: | 2020 |
| Collection: | LCC:Dermatology |
| Subject Terms: | Atopic dermatitis, Burden, Ocular disorders, Symptoms, Survey, Dermatology, RL1-803 |
| More Details: | Abstract Introduction Patients with atopic dermatitis (AD) have a greater risk of conjunctivitis and other ocular surface disorders than the general population. We evaluated the burden of ocular surface disorders and related symptoms prior to treatment initiation in adults with moderate-to-severe AD. Methods Patients were enrolled in a randomized, placebo-controlled, double-blinded, phase 3 trial of dupilumab administered with concomitant topical corticosteroids. At the beginning of the screening period, all enrolled patients completed a survey of ocular disorder diagnoses received in the past year; at baseline, patients completed a survey of frequency and severity of ocular symptoms (discomfort, itching, redness, and tearing) experienced in the past month. Results A total of 712 of 740 patients enrolled in the trial provided responses to the survey. At screening, 286 of 740 patients (38.6%) reported having at least one ocular disorder in the past year. At baseline, 499 of 712 respondents (70.1%) reported having at least one symptom within the past month. Of these patients, 4.4%, 6.0%, 5.5%, and 4.4%, respectively, reported having discomfort, itching, redness, and tearing all of the time. Mild discomfort, itching, redness, and tearing were reported by 26.1%, 33.7%, 30.8%, and 31.6% of patients, respectively, while 7.3%, 7.7%, 6.2%, and 4.2%, reported severe discomfort, itching, redness, and tearing, respectively. Conclusions These data demonstrate a high burden of ocular surface disorders and related symptoms in a population of adults with moderate-to-severe AD. Dermatologists should be aware of increased incidence of these disorders in AD and query their patients for signs and symptoms of eye disease. ClinicalTrials.gov Registration Number NCT02260986. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2193-8210 2190-9172 31593186 |
| Relation: | https://doaj.org/toc/2193-8210; https://doaj.org/toc/2190-9172 |
| DOI: | 10.1007/s13555-020-00456-x |
| Access URL: | https://doaj.org/article/920e3159318648358a69961d63cd33e9 |
| Accession Number: | edsdoj.920e3159318648358a69961d63cd33e9 |
| Database: | Directory of Open Access Journals |
| ISSN: | 21938210 21909172 31593186 |
|---|---|
| DOI: | 10.1007/s13555-020-00456-x |
| Published in: | Dermatology and Therapy |
| Language: | English |